Updated on 2026/07/10

写真a

 
Kawasaki Norihito
 
Affiliation
Musashikosugi Hospital, Department of Thoracic Surgery, Assistant Professor
Title
Assistant Professor
External link

Papers

  • Two Surgical Cases of Thymic Tumor Requiring Resection and Reconstruction of the Superior Vena Cava and the Brachiocephalic Vein.

    Makoto Shirakawa, Hikari Kimura, Ryosuke Amitani, Kenji Suzuki, Yasuo Miyagi, Jiro Honda, Kento Suzuki, Takumi Sonokawa, Yuichiro Machida, Norihito Kawasaki, Jitsuo Usuda, Yosuke Ishii

    Annals of vascular diseases   19 ( 1 )   2026

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Surgery for thymic tumor involving major vessels remains challenging; however, complete surgical resection is recommended when the resected major vessels can be reconstructed safely. Two cases are described in this report. In Case 1, complete surgical resection followed by reconstruction using an autologous pericardial patch was achieved owing to the temporary bypass assist. In Case 2, complete surgical resection followed by reconstruction using an autologous pericardial roll was achieved owing to the cardiopulmonary bypass assist. Complete surgical resection of thymic tumor involving the major veins can be achieved safely with appropriate extracorporeal circulatory assist. Autologous pericardium is useful for venous reconstruction.

    DOI： 10.3400/avd.cr.25-00145

    PubMed

    researchmap

  • Surgical Outcomes and Prognostic Impact of Lung Cancer Associated with Cystic Airspaces: A Retrospective Analysis of 75 Cases.

    Yuichiro Machida, Kento Suzuki, Mitsunobu Ino, Takumi Sonokawa, Norihito Kawasaki, Jitsuo Usuda

    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia   32 ( 1 )   2026

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    PURPOSE: The present study reviewed surgical cases of lung cancer associated with cystic airspace (LCCA) and examined the imaging and clinicopathological features of these cases. METHODS: A total of 75 patients with lung cancer associated with cystic airspace, who underwent lung cancer surgery in our hospital between January 2017 and December 2020, were included. We retrospectively analyzed the association between postoperative recurrence of lung cancer and lung cancer associated with the cystic airspace using the Cox proportional hazards model. RESULTS: Patients with LCCA had a worse prognosis than those with non-LCCA. Furthermore, a univariate analysis showed a significant difference between sex, smoking, differentiation, tumor size, Stage, and LCCA, while a multivariate analysis showed a significant difference between Stage and LCCA. LCCA cases were classified into four categories, as reported in a previous study. Types I and III showed more adenocarcinomas, while Type IV tended to show squamous cell carcinomas. CONCLUSIONS: LCCA has a poor prognosis. It is often difficult to determine which of the T factors of the TNM classification are applied. Therefore, further studies are needed to accumulate more LCCA cases.

    DOI： 10.5761/atcs.oa.25-00070

    PubMed

    researchmap

  • 浸潤性胸腺腫に対してロボット支援下手術から胸骨正中切開アプローチへ移行しSVC合併切除した一例

    鈴木 健人, 稲生 充伸, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 臼田 実男

    肺癌   65 ( 5 )   362 - 362   2025.11

    　More details

    Language：Japanese   Publisher：(NPO)日本肺癌学会  

    researchmap

  • 体外循環下に切除した上大静脈腕頭静脈右上中葉浸潤を認めた浸潤性胸腺腫の1切除例

    小嶋 隆, 富岡 勇宇也, 鈴木 健人, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 臼田 実男

    日本胸部外科学会関東甲信越地方会要旨集   ( 199回 )   35 - 35   2025.11

    　More details

    Language：Japanese   Publisher：日本胸部外科学会-関東甲信越地方会  

    researchmap

  • 気管腫瘍による高度気道狭窄に対してECMO下に気道開大術を施行した2例

    富岡 勇宇也, 小嶋 隆, 鈴木 健人, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 岡本 淳一, 臼田 実男

    気管支学   47 ( 6 )   585 - 585   2025.11

    　More details

    Language：Japanese   Publisher：(一社)日本呼吸器内視鏡学会  

    researchmap

  • 気腫性肺嚢胞関連肺癌(lung cancer associated with cystic airspaces:LCCA)の予後因子を考える

    町田 雄一郎, 鈴木 健人, 富岡 勇宇也, 園川 卓海, 川崎 徳仁, 臼田 実男

    肺癌   65 ( 5 )   441 - 441   2025.11

    　More details

    Language：Japanese   Publisher：(NPO)日本肺癌学会  

    researchmap

  • 胸骨正中切開に右第4肋間開胸を追加し完全切除した浸潤性胸腺腫の1例

    稲生 充伸, 小嶋 隆, 鈴木 健人, 園川 卓海, 町田 雄一郎, 岡本 淳一, 川崎 徳仁, 臼田 実男

    肺癌   65 ( 5 )   695 - 695   2025.11

    　More details

    Language：Japanese   Publisher：(NPO)日本肺癌学会  

    researchmap

  • 臨床病期IV期肺癌に対して薬物療法後にサルベージ手術を施行した一例

    小嶋 隆, 園川 卓海, 稲生 充信, 鈴木 健人, 町田 雄一郎, 川崎 徳仁, 岡本 淳, 寺崎 泰弘, 臼田 実男

    肺癌   65 ( 5 )   700 - 700   2025.11

    　More details

    Language：Japanese   Publisher：(NPO)日本肺癌学会  

    researchmap

  • cN2右上葉肺癌に対してCBCDCA+PTX+Nivolumabによる術前導入療法後に手術を施行した一例

    園川 卓海, 稲生 充伸, 鈴木 健人, 町田 雄一郎, 川崎 徳仁, 岡本 淳一, 臼田 実男

    肺癌   65 ( 5 )   661 - 661   2025.11

    　More details

    Language：Japanese   Publisher：(NPO)日本肺癌学会  

    researchmap

  • 間質性肺炎合併肺癌に対するリスクスコアと予後の検討

    富岡 勇宇也, 小嶋 隆, 鈴木 健人, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 臼田 実男

    肺癌   65 ( 5 )   491 - 491   2025.11

    　More details

    Language：Japanese   Publisher：(NPO)日本肺癌学会  

    researchmap

  • 手術を施行した間質性肺炎合併肺癌の予後の検討 術後予後の改善を目指して

    町田 雄一郎, 鈴木 健人, 園川 卓海, 川崎 徳仁, 臼田 実男

    日本胸部外科学会定期学術集会   78回   LMO9 - 1   2025.10

    　More details

    Language：Japanese   Publisher：(一社)日本胸部外科学会  

    researchmap

  • 間質性肺炎合併肺癌に対する手術戦略とリスクスコアリングシステムの検討

    富岡 勇宇也, 小嶋 隆, 鈴木 健人, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 臼田 実男

    日本胸部外科学会定期学術集会   78回   LOP16 - 5   2025.10

    　More details

    Language：Japanese   Publisher：(一社)日本胸部外科学会  

    researchmap

  • 炎症性肺疾患に対する外科的治療の成績

    園川 卓海, 小嶋 隆, 稲生 充伸, 鈴木 健人, 町田 雄一郎, 川崎 徳仁, 岡本 淳一, 臼田 実男

    日本胸部外科学会定期学術集会   78回   LMO5 - 11   2025.10

    　More details

    Language：Japanese   Publisher：(一社)日本胸部外科学会  

    researchmap

  • 中枢悪性気道病変に対する硬性気管支鏡下レーザー焼灼術

    町田 雄一郎, 鈴木 健人, 稲生 充伸, 園川 卓海, 川崎 徳仁, 臼田 実男

    気管支学   47 ( Suppl. )   S239 - S239   2025.5

    　More details

    Language：Japanese   Publisher：(一社)日本呼吸器内視鏡学会  

    researchmap

  • 中枢・末梢肺悪性病変に対する光線力学的治療法(PDT) 中心型肺癌に対する外来治療としてのPDTの検討

    園川 卓海, 稲生 充伸, 鈴木 健人, 町田 雄一郎, 川崎 徳仁, 岡本 淳一, 臼田 実男

    気管支学   47 ( Suppl. )   S187 - S187   2025.5

    　More details

    Language：Japanese   Publisher：(一社)日本呼吸器内視鏡学会  

    researchmap

  • 肺癌術後の多発肺癌に対する新しい気管支鏡治療法

    鈴木 健人, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 臼田 実男

    気管支学   47 ( Suppl. )   S160 - S160   2025.5

    　More details

    Language：Japanese   Publisher：(一社)日本呼吸器内視鏡学会  

    researchmap

  • 気管腺様嚢胞癌による気道狭窄に対してECMO下に腫瘍焼灼術を施行した一例

    小嶋 隆, 稲生 充伸, 鈴木 健人, 園川 卓海, 町田 雄一郎, 川崎 徳仁, 臼田 実男

    気管支学   47 ( Suppl. )   S388 - S388   2025.5

    　More details

    Language：Japanese   Publisher：(一社)日本呼吸器内視鏡学会  

    researchmap

  • 気道狭窄に対する呼吸器インターベンションにおけるECMOの有用性について

    稲生 充伸, 園川 卓海, 小嶋 隆, 鈴木 健人, 町田 雄一郎, 岡本 淳一, 川崎 徳仁, 臼田 実男

    気管支学   47 ( Suppl. )   S239 - S239   2025.5

    　More details

    Language：Japanese   Publisher：(一社)日本呼吸器内視鏡学会  

    researchmap

  • Long-term outcomes of PDT for centrally-located early lung cancers with tumor diameters > 2.0 cm. International journal

    Takumi Sonokawa, Mitsunobu Ino, Satoshi Kera, Mariko Tanaka, Kento Suzuki, Yuuya Tomioka, Yuichiro Machida, Norihito Kawasaki, Jitsuo Usuda

    Photodiagnosis and photodynamic therapy   47   104200 - 104200   2024.6

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: Photodynamic therapy (PDT) is used for the treatment of centrally-located early lung cancers (CLELCs) and is recommended for tumors ≤ 1.0 cm in diameter. We previously reported that PDT using talaporfin sodium, second-generation photosensitizer, for tumors > 1.0 cm but ≤ 2.0 cm in diameter was able to achieve a therapeutic outcome comparable to that of tumors with a diameter of ≤ 1.0 cm. However, the effectiveness of PDT using talaporfin sodium for tumors > 2.0 cm in diameter remains unclear. We conducted a retrospective analysis of cases in which PDT was performed for flat-type CLELCs with tumor diameters of > 2.0 cm. METHODS: We retrospectively analyzed seven cases (eight lesions) with tumor diameters > 2.0 cm and no evidence of extracartilaginous invasion or lymph node metastasis. RESULTS: All the patients underwent multiple PDT sessions. The PDT treatment results over the study period were partial response in one case (14.3 %), stable disease (SD) in three cases (42.9 %), and progressive disease (PD) in three cases (42.9 %). At the time of writing this report, five of seven cases (71.4 %) are still undergoing treatment. The duration of SD-the time from the start of treatment until the criteria for PD were met (SD or better maintained)-ranged from 7 to 52 months (mean, 25.3 months). CONCLUSIONS: "Maintenance PDT" for CLELCs > 2.0 cm in diameter has the potential to inhibit tumor progression in the long term while maintaining quality of life, rather than simply aiming only for a quick radical cure.

    DOI： 10.1016/j.pdpdt.2024.104200

    PubMed

    researchmap

▼display all